| Literature DB >> 31900332 |
Rafael Hoyos-Manchado1, Sergio Villa-Consuegra1, Modesto Berraquero1, Juan Jiménez2, Víctor A Tallada2.
Abstract
Forward genetics in model organisms has boosted our knowledge of the genetic bases of development, aging, and human diseases. In this experimental pipeline, it is crucial to start by inducing a large number of random mutations in the genome of the model organism to search for phenotypes of interest. Many chemical mutagens are used to this end because most of them display particular reactivity properties and act differently over DNA. Here we report the use of N-ethyl-N-nitrosourea (ENU) as a mutagen in the fission yeast Schizosaccharomyces pombe As opposed to many other alkylating agents, ENU only induces an S N 1-type reaction with a low s constant (s = 0.26), attacking preferentially O2 and O4 in thymine and O6 deoxyguanosine, leading to base substitutions rather than indels, which are extremely rare in its resulting mutagenic repertoire. Using ENU, we gathered a collection of 13 temperature-sensitive mutants and 80 auxotrophic mutants including two deleterious alleles of the human ortholog ATIC. Defective alleles of this gene cause AICA-ribosiduria, a severe genetic disease. In this screen, we also identified 13 aminoglycoside-resistance inactivating mutations in APH genes. Mutations reported here may be of interest for metabolism related diseases and antibiotic resistance research fields.Entities:
Keywords: ATIC; Ade10; N-ethyl-N-nitrosourea; S.pombe; auxotrophy; mutagenesis; phosphotransferase; ribosiduria
Mesh:
Substances:
Year: 2020 PMID: 31900332 PMCID: PMC7056981 DOI: 10.1534/g3.119.400936
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Figure 1Schematics of the experimental design. (A) Fission yeast cells (975 taxon) bearing KanMX6 and HphMX6 resistance markers were grown in rich medium (YES) until the early log phase and then split into four tubes. The first and third represent untreated controls while the second and fourth were treated with EMS and ENU respectively. (B) The same number of cells, aimed at 500, from each tube in “A” were plated in three technical replicates. The differences between the control and experiment plates were calculated for an estimation of cell survival after exposure to either alkylating agent. (C) Cells exposed to EMS and ENU were grown in solid YES. The resulting colonies (3,840 EMS-treated and 4353 ENU-treated) were replica-plated into synthetic minimal medium (MM) without supplements to identify auxotrophic mutants. (D) Another batch of 45,000 ENU-treated colonies was grown on YES plates as in “C” but replica-plated into YES containing G418 and hygromycin B (Hyg) antibiotics. Colonies sensitive to either antibiotic were selected and their resistance marker gene amplified and sequenced.
Survival rate after EMS and ENU treatments
| Expected cells/plate | Observed cells/plate (3 replicates) | Observed average | %Survival control | |
|---|---|---|---|---|
| Control EMS | 500 | 350/399/390 | 379.67 | 61.72% |
| EMS 0.3M | 500 | 206/266/231 | 234.33 | |
| Control ENU | 500 | 520/524/553 | 532.33 | 59.17% |
| ENU 0.03M | 500 | 310/314/321 | 315 |
Frequency of auxotrophic mutants
| EMS | ENU(1) | ENU(2) | Control | |
|---|---|---|---|---|
| na | na | 13 | 0 | |
| Leu- | 1 | 1 | na | na |
| Ura- | 2 | 0 | na | na |
| Ade- | 4 | 9 | na | na |
| His- | 2 | 4 | na | na |
| Other auxotrophs | 12 | 16 | na | na |
| Total auxotrophs | 21 | 28 | 52 | 0 |
| Colonies analyzed | 3,840 | 4,353 | 10,000 | 8,000 |
| Metabolic loss-of function frequency | 0.55% | 0.64% | 0.52% | 0 |
Numbers (1) and (2) denote the first and second screen.
Temperature-sensitive mutants.
Not assessed.
Two of them are both ade- and his-.
See footnote d.
Mutational spectrum of ENU in fission yeast
| Base pair change | Marker | Nucleotide change | Amino acid change |
|---|---|---|---|
| A-T | Kan | T375C | Val192Ala |
| A-T | Kan | T634C | Cys212Arg |
| A-T | Kan | T734C | Leu245Pro |
| A-T | Hph | T604C | Ser202Pro |
| A-T | Ade10 | T1270C | Ser424Pro |
| A-T | Ade10 | T203C | Val68Ala |
| A-T | Kan | T626A | Leu209STOP |
| A-T | Kan | T786A | His262Gln |
| A-T | Kan | T245A | Ile82Asn |
| A-T | Kan | T172A | Ser58Cys |
| A-T | Hph | A182C | Asp61Ala |
| A-T | Hph | T146G | Leu49Arg |
| G-C | Hph | G293A | Gly98Asp |
| G-C | Hph | C605T | Ser202Phe |
| G-C | Kan | C275A | Ala92Glu |
pFA6a numbering (Bähler ).
Figure 2Evolutionary conservation of ADE10/ATIC gene. (A) Frequencies of residues found in position 68 and 424 (S. pombe numbering) within all ortholog sequences available in Ensembl database. (B) Alignment of respective surrounding sequence stretches around residues 68 and 424. Representative prokaryotic and eukaryotic model organisms are included. Valine and Serine present in S. pombe are tightly conserved in other yeasts and animals including human.
Figure 3Second screen. Cells were processed as in the first screen for control and ENU treatments and plated in YES. Auxotrophs and temperature-sensitive mutants were found in ENU-treated cells but not in the untreated control. Another batch of 75,000 ENU-treated colonies was also replica-plated to YES containing G418 and hygromycin B (Hyg) to isolate and sequence resistance-loss mutations.